Ashwani Gujral (Technical Analyst), is of the view that Cipla shares can test Rs 450 level soon.

“Pharma is the only sector which is making fresh highs but that can’t take the market beyond 5200. Above Rs 310 Cipla is poised for levels of about Rs 450 over the medium term.”

He further added, “Biocon could now head upto Rs 332. It has got support at Rs 280.”

Cipla has touched a 52-week high of Rs 362.90. Its marketcap is Rs 28,523.78 crore and currently it is 107.02% above the 52-week low of Rs 171.60.

Source : MoneyControl

Related posts:

1. Cipla to raise Rs 676 crore via QIP Cipla is a pharmaceutical major of India and is...
2. Max India raising Rs 450 cr via QIP Max India Ltd board has approved raising up to Rs...
3. Muhurat Trading : Sensex ends on a flat note Today on Diwali Day, Market opens for a special...
4. Yes Bank can test Rs 327: Motilal Oswal Motilal Oswal is bullish on Yes Bank and has...
5. Buy Reliance @ Rs 900-950 for Long Term : Gujral Ashwani Gujral (Technical Analyst), is of the view that...

Related posts brought to you by Yet Another Related Posts Plugin.